44 min listen
SCOTUS Abortion Ruling Roils Corporations and Big Law
FromOn The Merits
ratings:
Length:
18 minutes
Released:
Jul 12, 2022
Format:
Podcast episode
Description
The Supreme Court's landmark Dobbs v. Jackson Women’s Health Organization ruling last month was the end of Roe v. Wade, but the beginning of a whole new era of turmoil over reproductive rights in corporate America.
For example, big corporations and law firms are weighing whether they should offer to pay for their employees to travel to receive an abortion. And if they do, how to respond if Republican lawmakers retaliate against them. Will some of these companies play both sides of the issue and continue to donate to GOP lawmakers, while publicly denouncing the abortion laws they enact?
Beyond corporate politics, there's also the more tangible issue of health care access. Some new state anti-abortion laws place restrictions on drugs that can terminate a pregnancy. But some doctors, pharmacists, and patients say it's unclear if it's still legal to prescribe these drugs for vital off-label uses.
Bloomberg Law has been covering all of the fallout from the abortion ruling, and on this week's episode of On The Merits, our weekly legal news podcast, reporters Maia Spoto, Clara Hudson, and Celine Castronuovo dig into all of the new issues that have arisen in the past few weeks.
Do you have feedback on this episode of On The Merits? Give us a call and leave a voicemail at 703-341-3690.
For example, big corporations and law firms are weighing whether they should offer to pay for their employees to travel to receive an abortion. And if they do, how to respond if Republican lawmakers retaliate against them. Will some of these companies play both sides of the issue and continue to donate to GOP lawmakers, while publicly denouncing the abortion laws they enact?
Beyond corporate politics, there's also the more tangible issue of health care access. Some new state anti-abortion laws place restrictions on drugs that can terminate a pregnancy. But some doctors, pharmacists, and patients say it's unclear if it's still legal to prescribe these drugs for vital off-label uses.
Bloomberg Law has been covering all of the fallout from the abortion ruling, and on this week's episode of On The Merits, our weekly legal news podcast, reporters Maia Spoto, Clara Hudson, and Celine Castronuovo dig into all of the new issues that have arisen in the past few weeks.
Do you have feedback on this episode of On The Merits? Give us a call and leave a voicemail at 703-341-3690.
Released:
Jul 12, 2022
Format:
Podcast episode
Titles in the series (100)
Peter Lattman: The Exit Interview: Peter Lattman, formerly of The New York Times, jo… by On The Merits